ABSTRACT
INTRODUCTION
The remarkable resistance of the mucosa of the upper gastrointestinal tract to concentrated gastric acid remains one of the biggest unsolved mysteries of upper gastrointestinal physiology (1) . It is assumed that an overproduction of gastric acid is the most important factor in the development of peptic ulcer, however it has also been demonstrated that gastric defense mechanisms which prevent mucosal injury are enhanced by same factors that increase acid secretion
(2).
Helicobacter pylori is the main cause of gastritis ,gastroduodenal ulcer and gastric cancer and should be considered as a major public health issue .According to several international guidelines first line therapy for treating Helicbopacter pylori infection consists of the usage of the macrolide antibiotic clarithromycin in combination with antisecretory agents usually proton pump inhibitor or H 2 receptor antagonist. Clarithromycin decreases the relapse of duodenal ulcer, and eradicates Helicobacter pylori from the gastric mucosa (3,4) . However, it is not well known if clarithromycin does have any cytoprotective effect against necrotizing agents on gastric mucosa (3,4) . A systemic evaluation of the various gastric protective mechanisms indicates that, a number of mechanisms have been postulated to play a role in defending the gastric mucosa against injury by noxious agents. These include: stimulation of opiate receptors, sulfhydryl agents, (7, 8) increase in mucosal blood flow, (9) stimulation of mucous synthesis (10) and increase in gastric fluid volume and hence dilution of the injurious agent.
(11)
Moreover, the histochemical studies have demonstrated adrenergic innervation of the gastric mucosa in rat and guinea pigs.
(12) Stimulation of -or -adrenoceptores has been demonstrated to play a role in defending the gastric mucosa against injury by noxious agents and stress.
(13,14) The present study was undertaken to examine whether clarithromycin may have any gastroprotective effect against 96% ethanol induced gastric mucosal lesions in rats, and to test the hypothesis that one or more of the following may mediate the gastric protection induced by intragastric administration of clarithromycin: 1-Activation of opiate receptors. 2-Stimulation of capsaicin-sensitive afferent sensory fibers. 3-Activation of  & -adrenoceptores. 4-Synthesis of endogenous prostaglandin. 5-Synthesis of endogenous sulfhydryls. 6-Increase in mucous and fluid volume retained in the gastric lumen at the time when ethanol is administrated. Thus, the aim of the present study was focused on the underlying mechanisms related to the possible cytoprotective effect of intragastric clarithromycin against the damage induced by 96% ethanol in rats other than its antibacterial action.
METHODS
Male albino rats weighing 180-220 gm, aging six months were utilized for this study. The animals were kept in cages with wide meshed galvanized wire bottoms to decrease coprophagy as much as possible. The rats were fasted for 24 h before the experiments but water was allowed adlibitum. Each study was carried out using six to eight rats per group. Ethanol-induced gastric mucosal lesions ( 15, 16) Gastric lesions were induced by the oral administration of 96% ethanol (by a gavage needle, 1 ml/rat) one hour later the animals were sacrificed. The stomachs were removed, opened along the greater curvature, stretched out and fixed into cardboard with insect pins. The luminal debris was washed off with saline. The mucosal injury was scored on the basis of lesion diameter according to Abou Zeit Har et al.
(17)
In this injury study, only gross lesions were assessed, because it has been demonstrated that there is a significant linear correlation between the extent of gross and histologic deep necrotic lesions induced by ethanol in the gastric mucosa. Six groups of rats were used (6 rats each): Group 1 (control): received intragastric vehicle (distilled water, 10 ml/kg b. wt.). Groups 2, 3, 4, 5: calrithromycin was given intragastricaly at 400, 200, 100, and 50 mg/kg b. wt.
(15)
Group 6: calrithromycin was given subcutaneously at 400 mg/kg b. wt.
Calrithromycin was given half an hour before 96% ethanol (10ml/kg b. wt. administration in all groups).
One hour after ethanol administration, the rats were sacrificed and examined as mentioned before for evaluation of lesions. Study II: Effect of blockade of opiate receptors on clarithromycin protective effect (Naloxone study):
A specific antagonist of , k and  opiate receptors naloxone hydrochloride was dissolved in deionized water.
(19) Rats were divided into four groups: Group 1 and 2 corresponded to strict controls and they received vehicle (deionized water2 ml/kg b. wt) intraperitoneally. Group 3 and 4 received opiate receptor antagonist 8 mg/kg b. wt. intraperitoneally (20) . After half an hour, group 1 and 3 were treated with vehicle (intragastric deionized water) and group 2 and 4 were treated with clarithromycin (groups 2 and 4 were subdivided into two subgroups (n=6 each) to allow for intragastric use of clarithromycin at 100 and 400 mg/kg b. wt.) after another one hour, 96% ethanol was administered intragastrically to all the rats. One hour after ethanol treatment, rats were sacrificed and the gastric mucosal lesions were examined as described in study. I. Study III: Effect of denervation of capsaicin afferent sensory nerve fibers on clarithromycin protective effect (capsaicin study):
Capsaicin was dissolved in the vehicle which consisted of 10% ethanol and 80%saline (20) . All rats received a total dose of 125 mg/kg b.
wt. of capsaicin subcutaneously over two days (20) . After confirming the functional denervation of the capsaicin-sensitive afferent sensory fibers (by the eye test) (21) . The injury study was carried out (after 10 days) in these sensory denervated and control rats using the same design as in the pervious study (naloxon study). Study IV: Effect of blockade of  adrenoceptors on clarithromycin protective effect:
This study was performed to test the effect of blockade of  1 and  2 adrenoceptors by prazosin or yohimbine, respectively, on the intragastric clarithromycin protection against 96% ethanol-induced gastric mucosal injury. The doses of  adrenoceptors blocking agents which were chosen in this study had been shown previously to block  1 and  2 adrenoceptors (22,23) . Rats were divided into six groups. Groups 1 and 2 were controls, and they received control pretreatment (deionized water 5 ml/kg b. wt. subcutaneously).
Groups 3 and 4 were pretreated with  1 blocking agent (0.5 mg/kg b.
wt., 5 ml/kg b. wt. subcutaneously) (22) . Groups 5 and 6 pretreated with  2 bloking agent (5 mg/kg b. wt., 5 ml/kg b. wt. subcutaneously) (23) . After 30 min., rats in groups 1, 3, 5 were treated with vehicle (deionized water 10 ml/kg b. wt. intragastric) and rats in groups 2, 4, 6 were treated with clarithromycin intragastrically (groups 2, 4 and 6 were subdivided into subgroups to allow for the use of clarithromycin at doses of 100 and 400 mg/kg b. wt, n=6 for each dose). After another hour, 96% ethanol (10 ml/kg b. wt.) was administered intragastrically to all rats. One hour later, the rats were sacrificed and examined as mentioned before for evaluation of lesions. butoxamine hydrochloride, was dissolved in deionized water at a concentration of 1 or 2 mg/ml respectively. Rats were divided into six groups: group 1 and 2 received control treatment (deionized water 2 ml/kg intraperitoneally). Groups 3 and 4 received pretreatment with  1 -adrenoceptor antagonist (2 mg/kg b. wt., 2 ml/kg b. wt. intraperiloneally).
(24) Groups 5 and 6 were pretreated with  2 adrenoceptor antagonist (4 mg/kg b. wt., 2 ml/kg b. wt. intraperitoneally).
(26)
Subsequent procedures were similar to those in the previous study, after pretreatment with the  adrenoceptor antagonists. Study VI: Effect of a cyclooxygenase inhibitor (indomethacin) and sulfhydryl blocker (iodoacetamide) on clarithromycin protection: Gastric endogenous prostaglandins (PGs), and sulfhydryl compounds were postulated to be involved in the mechanism of mild irritant or other agents.
(8,27) Therefore, the participation of PGs and sulfhydryls in the mechanism of the protective effect of clarithromycin was examined. Three groups of rats were used: group 1: the vehicle was given to the control rats subcutaneously (10 ml/kg b. wt.). Groups 2 and 3: either cycloxygenase inhibitor or sulfhydryl bloker dissolved in distal water) was given subcutaneously at 5 or 100 mg/kg b. wt. respectively in a volume of 10 ml/kg b. wt. One hour later, 96% ethanol was given intragastrically and the animals were sacrificed 60 min. later. Clarithromycin (100, 400 mg/kg b. wt.) was given intragastrically half an hour before ethanol.
Groups 2 and 3 were subdivided into two subgroups (n=6 each) to allow for the administration of the two doses of clarithromycin (100 and 400 mg/kg b. wt.). Study VII: Effect of clarithromycin on the volume of gastric content:
This study examined the effect of intragastric clarithromycin on gastric fluid volume and gastric mucous volume retained in the gastric lumen.
(20) In this study, rats were divided into five groups treated with vehicle or clarithromycin at different doses as in study I. Thirty min. later, rats were sacrificed (ethanol was not administered). After laparotomy, the pylorus and the esophagogastric junction were ligated and the stomach was removed. Gastric content was gently expressed from the stomach via incision made in the fore stomach by pressing the stomach between cotton tip applicator and the wall of a plastic funnel and letting the gastric juice flow into the graduated test tube. The volume of the gastric juice to the nearest 0.01 ml was measured. The gastric mucous volume to the nearest 0.01 ml was also assessed by placing the mucous in a 1 ml graduated syringe (28) . All volume measurements were confirmed by an unbiased observer who was unaware of the treatment.
Study VIII: Effect of varying gastric fluid volume on 96% ethanol-induced lesions:
It was found that 30 min. after administration of vehicle or clarithromycin 100 or 400 mg/kg b. wt., the vehicle group had about 51 l gastric fluid, the clarithromycin (100 mg/kg b. wt.) group had 396.5 l of gastric fluid and the clarithromycin (400mg/kg b. wt.) group had 840 l of gastric fluid retained in the stomach. Accordingly the animals were divided into three groups. Group 1 received 60 ul, group 2 received 400 ul, group 3 received 900 ul of vehicle (distilled water) intragastrically immediately before treatment with 96% ethanol (gavage needle, 1 ml/rat) one hour later, the animals were sacrificed and the gastric lesions were evaluated as indicated in study I. Study IX: The effect of clarithromycin on gastric mucous volume, gastric juice volume and titratable acid in gastric juice after subcutaneous  2 -blockade.
The animals were divided into four groups. Groups 1 and 2 received distilled water, subcutaneoulsy (10 ml/kg b. wt.). Groups 3 and 4 received  2 -blocker (5 mg/kg b. wt. (10 ml/kg b. wt.) subcutaneously after 30 min, animals in groups 1 and 3 were treated with vehicle (distilled water 10 ml/kg b. wt. intragastric) and animals in groups 2 and 4 were treated with clarithromycin (400 mg/kg b. wt., 10 ml/kg b. wt intragastric). After another 30 min, the animals were killed. The volume of gastric mucous and the volume of gastric fluid were measured separately as indicated in study VII. Acid content in the gastric juice was determined by titration of aliquots of the gastric juice with 0.1 N NaOH to pH 7.0. Total acid output was then calculated in units of micro equivalents. As presented in Fig. 2 , despite the blockade of the opiate receptors by intragastric clarithromycin at doses of 100, and 400 mg/kg b.wt. produced a significant reduction in the lesion score (9.1660.752 and 1.5000.547 respectively vs 19.000, p< 0.05). These data indicated that pretreatment with opiate blocker did not abolish the protective effect of the intragastric clarithromycin against ethanolinduced gastric mucosal lesion (Fig.  2) . Effect of denervation of capsaicin afferent sensory nerve fibers on clarithromycin protection (Capsaicin study) -All the capsaicin treated rats failed to show the wiping response, indicating that the pretreatment was effective in functionally denervating the afferent sensory fibers.
-Despite denervation of capsaicin afferent sensory nerve, intragastric clarithromycin at doses of 100 and 400 mg/kg b.wt. produced a significant reduction in lesion score as compared to the vehicle value (9.000.752 and 1.6670.816 respectively vs 19.000, p< 0.05). Thus, denervation of capsaicin afferent sensory nerve did not abolish the protective effect of intragastric clarithromycin at low and high doses. (Fig. 3 ) Effect of blockade of -adrenoceptors on clarithromycin protection: -In the control rats the lesion scores in the clarithromycin groups were (at 100 and 400mg/kg b. wt.) significantly lower than that in the vehicle group. (Fig. 4 ) -In rats pretreated with  1 -adrenoceptor blocker, the lesion score in clarithromycin groups was significantly lower than that in the vehicle group and both of them showed insignificant change compared to the respective control. (Fig. 4 ) -In the  2 -blocker pretreated rats although the lesion score in the clarithromycin groups (100-400 mg/kg b. wt.) was significantly lower than that in the vehicle group, they were significantly higher than those of the clarithromycin groups (16.1660.752 and 14.0000.894 vs 9.1660.752 and 1.660.816 respectively, p< 0.05) in controls not given  2 -blocker pretreatment. (Fig. 4) -There was insignificant difference in the lesion scores (19.0000.894 vs 18.8331.1690, p> 0.05) between the vehicle-treated rats with  2 -blocker pretreatment and the vehicle-treated rats in the control group, indicating that  2 -blocker alone did not aggravate the lesions. (Fig. 4 ) Effect of blockade of -adrenoceptors on clarithromycin protection: -The lesion score in the clarithromycin groups (not given any -adrenoceptors antagonist) were significantly lower than that in the vehicle group. (Fig. 5 ) -In rats pretreated with either -1 or -2 adrenoceptor blocking agents, the lesion scores in the clarithromycin groups were significantly lower than those in the respective vehicle groups. This indicated that pretreatment with -1 or -2 antagonist did not abolish the protective effect of intragastric clarithromycin against 96% ethanol-induced gastric mucosal injury. (Fig. 5) 
Effect of cycloxygenase inhibitor and sulfhydryle blocking agent on clarithromycin protection:
Subcutaneous administration of cycloxygenase inhibitor (5mg/kg b. wt.) or sulfhydryle blocking agent (100mg/kg b. wt.) alone did not significantly modify the gastric lesions score induced by 96% ethanol. The protective effect of clarithromycin intragastrically administered at 100 or 400 mg/kg b. wt. was not affected by pretreatment with cycloxygenase inhibitor or sulfhydryle blocking agent (Fig. 6 ). These data indicated that these agents did not suppress the protective effect of intragastric clarithromycin at low or higher doses against ethanolinduced lesions. (Fig. 6 ) Effect of intragastric clarithromycin on volume of gastric content: -Clarithromycin in a dose dependent manner increased the fluid volume retained in the gastric lumen. Rats treated with clarithromycin at doses of 50, 100, 200, 400g/kg b. wt. had a significantly higher fluid volume as compared to the vehicle control groups (Table I) . Rats treated with clarithromycin at 400 mg/kg b. wt. had a higher fluid volume than rats treated with clarithromycin at doses of 50, 100 and 200 mg/kg b. wt. (Table I ).
-The gastric mucous volume in the rats treated with clarithromycin at doses of 100, 200 and 400 mg/kg b. wt. were significantly higher than that in the rats treated with vehicle (Table I ). -These results indicated that intragastric clarithromycin dosedependently increased gastric fluid volumes and that there was a significant increase in gastric mucous volume for clarythromycin 100, 200 and 400 mg/kg b. wt.
Effect of varying gastric fluid volume on 96% ethanol induced lesion:
It was found that half an hour after the administration of vehicle or clarithromycin at doses of 100 or 400mg/kg b. wt., the gastric fluid retained in the stomach were 51.98  21.02, 369.50  3.21 and 840.50  4.32 µl respectively. Accordingly, 60, 400, 900 µl of vehicle (distilled water) was instilled into the rat stomach immediately before ethanol. It was found that the lesion score in the rats treated with 60 µl of vehicle was significantly higher than that in the rats treated with 400 µl of vehicle and in rats treated with 900 µl of vehicle. This indicated that the higher gastric fluid volume retained in the gastric lumen of rats treated with different doses of clarithromycin accounted for the reduction in lesion. (Fig. 7) The effect of clarithromycin on gastric mucous volume, gastric juice volume and titratable acid in gastric juice after subcutaneous  2 -blocker: -It was found that both in the control or  2 blocker-pretreated rats, the gastric mucous volumes in the clarithromycin group were significantly higher than those in the respective vehicle groups (control groups 222. respectively, p>0.05). Gastric acid output values were significantly higher in the,  2 blocker pretreated rats than those in the respective controls. (Fig. 10 ). (Cl) given either intragastrically or subcutaneously on 96% ethanol induced gastric lesion in rats. Cl was given 30 min. before ethanol administration and the rats were sacricified 1hr after ethanol administration. Data represent the mean ± SD (n = 6 rats/group). * Statistically significant as compared to the control at p < 0.05.
Fig. (2):
Effect of blockade of opiate receptors by naloxone on the protective effect of intragastric clarithromycin against 96%ethanol induced gastric mucosal lesion. Thirty min prior to the injury study rats were pretreated with intraperitoneal deionized water (control) or opiate blocker (8mg/Kg b. wt.). The rats in each group were then given either intragastric vehicle or clarithromycin at 100 and 400 mg/Kg followed by 96% ethanol. Data represent the mean ± SD (n = 6 rats/group). * Statistically significant from the vehicle at p < 0.05. Opiate blocker Fig. (3) : Effect of sensory denervation by capsaicin on the protective effect of intragastric clarithromycin against 96% ethanol induced gastric lesion in rats.
Capsaicin was given in a dose of 125 mg/Kg S.C 10 days prior to the injury study. Data represent the mean ± SD (n = 6 rats/group). * Statistically significant from the vehicle at p < 0.05.
Fig. (4):
Effect of blockade of  adrenoceptors by  1 or  2 blocker on the protective effect of intragastric clarithromycin against gastric mucosal lesions induced by 96% ethanol. Thirty min prior to the injury study rats were retreated with  1 blocker (0.5 mg/Kg S.C) or  2 blocker (5 mg/Kg S.C) or vehicle (5 ml/Kg). The rats in each group were then given either intragastric vehicle (10 ml/Kg) or clarithromycin (100 and 400 mg/Kg, 10 ml/kg) followed by 96% ethanol 10 ml/Kg intragastric). Results are expressed as mean ± SD (n = 6 rats/group). * Statistically significant from the vehicle at p < 0.05 ** Statistically significant from respective control at p < 0.05 prior to the injury study rats were pretreated with intraperitoneal vehicle (2ml/Kg) or -l blocker (2mg/Kg) or -2 blocker(4mg/Kg). The rats in each group were then given either intragastric vehicle or clarithromycin (400 and 100 mg/Kg, 10 ml/Kg) followed by 96% ethanol. Results are expressed as mean ± SD (n = 6 rats/group). * Statistically significant as compared to vehicle. Effect of vehicle or clarithromycin (Cl) on gastric mucous volume in control and  2 blocker pretreated rats. Thiry min after subcutaneous distilled water (control 10 ml/Kg) or  2 blocker (5mg/Kg) rats were treated with intragastric vehicle (10 ml/Kg) or Cl (400 mg/Kg, 10 ml/Kg). Thirty minutes later, gastric mucous was collected and its volume was measured. Values are expressed as mean ± SD (n = 6 rats/group). * Significantly different from the vehicle at p <0.05. ** Significantly different from the control at p<0.05. Effect of vehicle or clarithromycin (Cl) on gastric juice volume in control and  2 blocker pretreated rats. Thirty minutes after subcutaneous distilled water (control, 10 ml/Kg) or  2 blocker (5 mg/Kg, 10 ml/kg), rats were treated with intragastric vehicle (10ml/Kg) or Cl (400 mg/Kg, 10 ml/Kg). Thirty min. later, gastric juice was collected and its volume was measured. Values are expressed as mean ± SD (n= 6 rats/group). * Significantly different as compared to vehicle.
Fig. (10):
Effect of intragastric vehicle or clarithromycin (Cl) on the titrable acid in gastric juice in control and  2 blocker pretreated rats. Rats were pretreated with subcutaneous distilled water (control, 10ml/Kg or  2 blocker 5 mg/Kg, 10 ml/Kg). Thirty min. later the rat were treated with intragastric vehicle (10 ml/Kg) or Cl (400 mg/Kg, 10 ml/Kg). Thirty min. later, gastric juice was collected and its volume was measured using graduated test tube. Acid content in the gastric juice was determined by titration of aliquots of the gastric juice (0.03-0.1ml depending on total acid output) with 0.1N NaOH to pH 7.0. Values represented as mean ± SD (n= 6 rats/group) * Significantly differnt as compared to the respective control. (43) In the present study, rats pretreated with capsaicin 125mg/kg subcutaneously, a dose known to produce functional denervation of the afferent sensory fibers (21) (this was confirmed by the absence of the wiping reflex when capsaicin in a low doses was introduced into the eyes of these rats).
In the current study, the protective effect of intragastric clarithromycin was not abolished by capsaicin pretreatment. This indicates that the protective effect of intragastric clarithromycin against ethanol-induced mucosal injury may not be mediated by afferent sensory nerve fibers.
The findings of the present study have demonstrated that pretreatment with (selective  1 -adrenoceptor antagonist) in a dose provided adequate  1 -blockade did not produce a significant reduction in the lesion score both in vehicle and clarithromycin treated rats (at different doses) meaning that clarithromycin treatment still produced a significant reduction in lesion score. This observation suggested that  1 -adrenoceptors seem to have no role in the pathogenesis of ethanol-induced gastric mucosal. This finding agrees in part with the finding of previous study (44) that suggested that  1 -adrenoceptors may play no or partial role in the pathogenesis of ethanol-induced gastric mucosal injury.
On the other hand, the present findings have shown that 2-adrenoceptor antagonist) significantly reduced but did not completely block the protective effect of intragastric clarithomycin, suggesting that stimulation of  2 -adrenoceptor by intragastric claithromycin may be involved partially in its protective effect against ethanol-induced gastric mucosal injury. The mechanism may be a mucous dependent since intragastric clarithromycin (in the present study) was found to increase both gastric mucous volume and gastric juice volume while yohimbine significantly reduced both basal and clarithromycin stimulated gastric mucous secretion.
This observation suggests that the blockade of the protective effect of intragastric clairithromycin by yohimbine was related to an effect on gastric mucous volume.
Previous studies (28,44) showed that different agents protected against ethanol and acetyl salicylic acid induced gastric damage in rats and this protection was associated with a significant increase in gastric juice and gastric mucous volumes. Endoh et al.
(44) have also reported that gastroprotective effect of intragastric nicotin and the significant increase in gastric mucous volume were significantly attenuated by as it has been shown in the present study that the mechanism of gastroprotection offered by intragasteric clarithromycin is also mediated by a similar factor. This supports the hypothesis that  2 -adrenoceptors modulate mucosal protection (44) . Thus gastric mucous volume and  2 adrenoceptors may be instrumental in the protective effect of a variety of agents administered intragastrically.
-adrenoceptors agonists a nonspecific agonist of  1 and  2 adrenoceptors (45) and selective agonist of  2 adrenoceptors (45) have been reported to inhibit gastric mucosal lesion induced by noxious agents and stress.
(44)
The results of the current study showed that blockade of -adrenoceptors did not enhance ethanol-induced gastric damage,pretreatment also did not modify the protective effect of intragastric clarithromycin. This indicates that  adrenoceptors do not play a role in the formation of ethanol-induced gastric mucosal lesions, or the protective effect of intragastric clarithromycin against such lesion. These data agree in part with the results of Endoh et al.
(46) who showed that (non selective -adrenoceptors antagonist in a dose that provided blockade of -adrenoceptors) did not abolish the protective effect of intragastric nicotine against ethanol induced gastric mucosal injury, suggesting that -adrenoceptors do not play a role in the formation of ethanol induced gastric mucosal lesion.
The results of the present study have revealed that the protective effect of clarithromycin was not significantly reduced by cyclooxygenase inhibitor (in a dose that is adequate to inhibit the cylo-oxygenase activities) (16) given before clarithromycin.
Therefore, clarithromycin protection dose not appear to involve stimulation of endogenous prostaglandin synthesis. This is in agreement with the finding obtained by Candido et al.
(15)
Subcutaneous administration of (100mg/kg b. wt.) a specific sulfhydryl blocker, significantly decreased non protein sulfhydryls of the gastric mucosa assessed by the spectrophotometric methods.
(27) It is well known that the action of sulfhydryls of the gastric mucosa is an important factor in modulating mucosal integrity in the presence of noxious agents. The present finding showed that clairthromycin maintained its gastroprotective effect in cyclo-oxygenase inhibitor treated animals. This strongly suggests that non-protein sulfhydryls and other iodoacetamide sensitive mechanisms are not involved in clairthromycin protection against ethanol injury.
Gastric mucous has a protective role against acid peptic damage by forming a stable unstirred layer that supports surface neutralization by bicarbonate, providing a diffusion barrier.
(10) Also, gastric mucin can act as an antioxidant.
(47) The possibility that interagastric clarithromycin may protect the gastric mucosa by enhancing gastric mucous volume was examined and it was found that intragastric administration of clarithtomycin (100-400 mg/kg b. wt.) was associated with a significant increase in gastric mucous volume half an hour after its administration and this may account for the protection of the underlying epithelium against the damage induced by ethanol.
It is probable that clairthromycin protects rats against ethanol-induced damage as a result of a dilution of the ethanol in solution. The results of the present study have shown that intragastric clairthromycin in a dose dependent manner has increased the fluid volume retained in the gastric lumen after half an hour. The higher gastric volume at the time of ethanol administration may have dilute the challenger solution, reducing the severity of the damage in clairthromycin treated rats. The importance of higher gastric juice fluid volume was studied. It has been found that intragastric clairthromycin produced an increase in the gastric fluid in a dose dependent manner accordingly three incremental amount of vehicle (60, 400, 900 l of distilled water) were administrated into the rat stomach immediately before ethanol. The present findings showed that the lesion score in the rats treated with 60l of vehicle was significantly higher than those treated with 400l or 900l of vehicle. This indicates that the higher fluid volume retained in the gastric lumen of clarithromycin treated rats may accounts for the reduction in the lesion score.
The data of the present study indicated that the protective effect of intragastric clairthromycin consists of a dilution effect and other effects such as an increase in gastric mucous production. The importance of the protective effect of the high gastric fluid volume and the increase in the mucous volume against ethanol was examined and confirmed by other investigators (11, 20, 28) who concluded that the greater increase in gastric juice volume and gastric mucosa volume have a major role in the protection of gastric mucous against damage induced by ethanol.
The findings of the present study have shown that intragastric clarithromycin was not associated with a reduction in the gastric acid secretion since there was no significant difference in titratable acid in gastric juice between vehicle and clarithromycin treated rats.  2 -adrenoceptor bloker itself enhanced gastric acid secretion in vehicle and clarithromycin treated rats, suggesting that acid secretion is not significantly involved in the protective effect of intragastric clarithromycin against ethanol damage. Accordingly, acid secretion did not play a significant role in the damaging action exerted by ethanol on gastric mucosa or the protective effect of intragastric clarithromycin against such lesion.
The acute protection of clarithromycin have a limited role in chronic ulcer healing. However, it was reported that intragastric clarithromycin has a protective effect despite using different gastric lesion models, this observation suggested that the protective effect of intragastric clarithromycin in not specific for the ethanol model. 
